Business Description
Runben Biotechnology Co Ltd
ISIN : CNE100006DK5
Share Class Description:
SHSE:603193: Ordinary Shares - Class ACompare
Compare
Traded in other countries / regions
603193.China IPO Date
2023-10-17Description
Runben Biotechnology Co Ltd is engaged in research & development, production and sales of mosquito repellent and personal care products.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 35.11 | |||||
| Equity-to-Asset | 0.95 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | 1288.84 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 50.31 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 26.4 | |||||
| 3-Year EBITDA Growth Rate | 28.3 | |||||
| 3-Year EPS without NRI Growth Rate | 25.3 | |||||
| 3-Year FCF Growth Rate | 92.3 | |||||
| 3-Year Book Growth Rate | 25.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.59 | |||||
| 9-Day RSI | 59.7 | |||||
| 14-Day RSI | 60.85 | |||||
| 6-1 Month Momentum % | 8.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 16.69 | |||||
| Quick Ratio | 15.35 | |||||
| Cash Ratio | 1.26 | |||||
| Days Inventory | 94.49 | |||||
| Days Sales Outstanding | 2.75 | |||||
| Days Payable | 47.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.82 | |||||
| Forward Dividend Yield % | 0.82 | |||||
| 5-Year Yield-on-Cost % | 0.82 | |||||
| 3-Year Average Share Buyback Ratio | -57.7 | |||||
| Shareholder Yield % | 0.84 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 56.75 | |||||
| Operating Margin % | 24.47 | |||||
| Net Margin % | 22.93 | |||||
| FCF Margin % | 23.7 | |||||
| ROE % | 17.09 | |||||
| ROA % | 15.91 | |||||
| ROIC % | 20.44 | |||||
| ROC (Joel Greenblatt) % | 28.48 | |||||
| ROCE % | 20.28 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 30.87 | |||||
| PE Ratio without NRI | 30.32 | |||||
| PS Ratio | 6.97 | |||||
| PB Ratio | 4.27 | |||||
| Price-to-Tangible-Book | 4.32 | |||||
| Price-to-Free-Cash-Flow | 28.23 | |||||
| Price-to-Operating-Cash-Flow | 27.27 | |||||
| EV-to-EBIT | 29.03 | |||||
| EV-to-EBITDA | 29.03 | |||||
| EV-to-Revenue | 7.92 | |||||
| EV-to-FCF | 34.37 | |||||
| Price-to-Graham-Number | 2.41 | |||||
| Price-to-Net-Current-Asset-Value | 5.07 | |||||
| Price-to-Net-Cash | 344.67 | |||||
| Earnings Yield (Greenblatt) % | 3.44 | |||||
| FCF Yield % | 2.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Runben Biotechnology Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,048.137 | ||
| EPS (TTM) (Â¥) | 0.67 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 60.85 | ||
| 14-Day ATR (Â¥) | 0.864345 | ||
| 20-Day SMA (Â¥) | 20.0435 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (Â¥) | 11.92 - 26.68 | ||
| Shares Outstanding (Mil) | 404.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Runben Biotechnology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Runben Biotechnology Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Runben Biotechnology Co Ltd Frequently Asked Questions
What is Runben Biotechnology Co Ltd(SHSE:603193)'s stock price today?
The current price of SHSE:603193 is ¥20.68. The 52 week high of SHSE:603193 is ¥26.68 and 52 week low is ¥11.92.
When is next earnings date of Runben Biotechnology Co Ltd(SHSE:603193)?
The next earnings date of Runben Biotechnology Co Ltd(SHSE:603193) is .
Does Runben Biotechnology Co Ltd(SHSE:603193) pay dividends? If so, how much?
The Dividend Yield %  of Runben Biotechnology Co Ltd(SHSE:603193) is 0.82% (As of Today), Highest Dividend Payout Ratio of Runben Biotechnology Co Ltd(SHSE:603193) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Runben Biotechnology Co Ltd(SHSE:603193) is 0.82%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers